Company
Headquarters: Paris, France
Employees: 47
CEO: Mr. Michel Finance
€53.3 Million
EUR as of July 1, 2025
US$63.0 Million
| Company | Market Cap (USD) |
|---|---|
| Abbott | $216.15 B |
| Boston Scientific Corporation | $140.40 B |
| Stryker | $133.15 B |
| Medtronic | $123.20 B |
| Edwards Lifesciences Corporation | $50.10 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Affluent Medical SA, a medical devices company, designs, develops, manufactures, and markets implantable prostheses devices in France. The company develops Kardiozis prosthesis for the noninvasive treatment of abdominal aortic aneurysm; Kalios and Epygon implants for the treatment of mitral insufficiency; and Artus implant, an artificial electromechanical implantable sphincter for severe urinary incontinence in women and men. The company was founded in 2011 and is headquartered in Aix-en-Provence, France.
Affluent Medical SA has the following listings and related stock indices.
Stock: Euronext: AFME wb_incandescent
Stock: FSX: 0JZ wb_incandescent